Our Technologies

Read about our available technologies and get in touch with our team




Clear all filters

Wearable enabling visually impaired user to hear echoes bounced back from structures and objects, allowing the user to perceive their spatial environment
Neurosurgical clip and actuator with stability and freedom of movement; non-invasive tumour identification probe for real-time mapping
Topical use of Capsaicin or TRPV 1 agonists for the prevention of diabetic ulcers in a patient suffering from diabetic peripheral neuropathy (DPN).
A binder-less, fully dry, room temperature electrode manufacturing technology — a sustainable, cost-effective, and efficient alternative.
A system designed for generating ultrafast mid-infrared laser pulses at the wavelength at which water molecules absorb light resonantly
A green chemistry solution to give discarded fabric a second chance, salvaging their dyes through dye recycling
Two patent-pending technologies for the creation of sustainably produced lignin-based carbon fibres
The Nanograb technology empowers scientists and doctors to selectively detect biomarkers by creating super-selective systems made out of DNA.
Carbon neutral cement aimed at increasing production of carbon neutral or negative concrete and decarbonisation of construction
A nutritional analytics platform harnessing networked AI and omics data to identify how dietary biomolecules and phytochemically rich “Hyperfoods” can help to prevent or fight diseases such as cancer or COVID-19

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Licensing and IP performance 2019/20

Inventions disclosed

Imperial inventors submitted 250 invention disclosures to our IPC team during the year

Active licences

Imperial College London's licensing portfolio comprises 244 licences

Patents filed

Imperial filed 137 patents (including PCT applications) during the year

Patent portfolio

Imperial's patent portfolio reached 331 patents during the year

Upcoming Events

Connect, Collaborate, Innovate 2023

Connect, Collaborate, Innovate 2023

Event date - November 1, 2023

Connect with leading academics in Innovate UK’s three innovation domains: Net Zero, Healthy Living, Digital and Technologies. Find out more

Latest News

Accelerated development of a potential treatment for cystic fibrosis

Accelerated development of a potential treatment for cystic fibrosis

The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more

Natural Killer – licensing a cell therapy

Natural Killer – licensing a cell therapy

Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more